HAHA. The report released last night shows how things have deteriorated. MAnagement very poor.
No need to buy this company unless we see some dramatic change and for me that means the MD needs to be the first to go. They need a strategic investor who also has some management expertise where they take a board position and drive the business.
Nothing positive here. In fact a major disappointment.
- Forums
- ASX - By Stock
- HRO
- Compelling opportunity
Compelling opportunity, page-11
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HRO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online